Novel treatment of ovarian cancer cell lines with Imatinib mesylate combined with Paclitaxel and Carboplatin leads to receptor-mediated antiproliferative effects (Q46605996)
Jump to navigation
Jump to search
scientific article published on 9 May 2008
Language | Label | Description | Also known as |
---|---|---|---|
English | Novel treatment of ovarian cancer cell lines with Imatinib mesylate combined with Paclitaxel and Carboplatin leads to receptor-mediated antiproliferative effects |
scientific article published on 9 May 2008 |
Statements
1 reference
Novel treatment of ovarian cancer cell lines with Imatinib mesylate combined with Paclitaxel and Carboplatin leads to receptor-mediated antiproliferative effects (English)
1 reference
1 reference
Ivo Meinhold-Heerlein
1 reference
Felix Hilpert
1 reference
Christoph Mundhenke
1 reference
Marion Tina Weigel
1 reference
Frank Roesel
1 reference
Dirk O Bauerschlag
1 reference
Christian Schem
1 reference
Walter Jonat
1 reference
Nicolai Maass
1 reference
9 May 2008
1 reference
134
1 reference
12
1 reference
1397-1405
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference